U.S. Communications Stock News

NYSE:CWAN
NYSE:CWANSoftware

Clearwater Analytics Holdings (CWAN) Quarterly Loss Challenges Bullish Profitability Narratives

Clearwater Analytics Holdings (CWAN) closed out FY 2025 with Q4 revenue of US$217.5 million and a basic EPS loss of US$0.04, as net income excluding extra items came in at a loss of US$12.1 million. Over recent periods the company has seen quarterly revenue move from US$126.5 million in Q4 FY 2024 to US$217.5 million in Q4 FY 2025, while basic EPS shifted from US$1.85 a share in Q4 FY 2024 to a loss of US$0.04 a share in the latest quarter. This sets up a results season in which investors are...
NYSE:FERG
NYSE:FERGTrade Distributors

Is Ferguson Enterprises (FERG) Still Fairly Priced After Recent Share Price Pullback?

If you are wondering whether Ferguson Enterprises at around US$246.53 is still worth your attention, it helps to start by separating price moves from underlying value. The stock has seen a 7.9% decline over the last 7 days, set against returns of 4.5% over 30 days, 9.6% year to date, 46.3% over 1 year, 78.6% over 3 years and 109.5% over 5 years. This naturally raises questions about how much future strength or risk is already reflected in the price. Recent coverage of Ferguson Enterprises...
NYSE:MNTN
NYSE:MNTNMedia

What MNTN (MNTN)'s Q1 Profit Rebound and QuickFrame AI 3.0 Launch Mean For Shareholders

MNTN, Inc. recently reported first-quarter 2026 results, with sales rising to US$73.67 million and net income improving to US$8.76 million, reversing a net loss a year earlier and lifting basic earnings per share from continuing operations to US$0.12. On the same day, the company launched QuickFrame AI 3.0, expanding its AI-powered creative platform into a full production workflow that lets brands rapidly generate, edit, and publish multi-format video ads across major digital and TV...
NasdaqGS:INSM
NasdaqGS:INSMBiotechs

Insmed (INSM) Q1 2026 Revenue Surge Tests Profitability Narrative

Insmed (INSM) opened Q1 2026 with revenue of US$306 million and a basic EPS loss of US$0.76, while the trailing twelve months show revenue of US$820 million and a basic EPS loss of US$5.70. Over the past reported quarters, revenue has moved from US$93 million in Q1 2025 to US$306 million in Q1 2026, alongside quarterly basic EPS losses ranging between US$0.76 and US$1.75. This keeps the focus squarely on how efficiently new sales translate into narrowing losses. For investors, the story this...
NasdaqGS:AFRM
NasdaqGS:AFRMDiversified Financial

Affirm Holdings (AFRM) Profitability Milestone Tests Bullish Narratives In Q2 2026 Earnings

Affirm Holdings (AFRM) opened its Q2 2026 update with total revenue of US$1.1b and basic EPS of US$0.39, alongside trailing twelve month revenue of US$3.7b and EPS of US$0.86 that put profitability firmly in focus. The company has seen quarterly revenue move from US$866.4m in Q2 2025 to US$1.1b in Q2 2026, while basic EPS shifted from US$0.25 to US$0.39 over the same period. This sets up this print as a key checkpoint on whether margins are starting to scale more consistently. See our full...
OTCPK:LKNC.Y
OTCPK:LKNC.YHospitality

Is It Time To Reassess Luckin Coffee (OTCPK:LKNC.Y) After Recent Share Price Swings?

Curious whether Luckin Coffee at US$33.44 is giving you real value or just headline noise? This article breaks down what the current price might be implying about the stock. The stock has been choppy recently, with a 4.5% decline over the last week, a 2.9% gain over the last 30 days, a 5.6% year to date decline, and a 2.9% return over the last year, on top of a 65.2% return over three years and a very large gain over five years. Recent coverage of Luckin Coffee has focused on its position in...
NasdaqGM:LUNR
NasdaqGM:LUNRAerospace & Defense

Is It Too Late To Consider Intuitive Machines (LUNR) After Its Recent Lunar Mission Headlines?

Wondering whether Intuitive Machines stock still offers value after its recent volatility, or if you might be turning up late to the story? The stock closed at US$24.11, with a 4.9% decline over the last 7 days, a 6.1% gain over 30 days, a 34.8% return year to date, and a 157.9% return over the past year. Recent headlines around Intuitive Machines have kept the stock in focus, with investors paying closer attention to how its projects translate into long term potential. This context helps...
NasdaqGM:AGNT
NasdaqGM:AGNTReal Estate

A Look At eXp World Holdings (AGNT) Valuation After Adding Veteran Broker Mario J Alvarez Jr

eXp World Holdings (AGNT) recently drew attention after eXp Commercial added veteran broker Mario J Alvarez Jr, whose two decades in commercial real estate align with the company’s effort to grow its investment sales presence. See our latest analysis for eXp World Holdings. At a share price of $6.60, eXp World Holdings has a 30 day share price return of 10.18% and a 7 day gain of 2.48%. However, the year to date share price return of 27.47% and 90 day share price return of 23.79% point to...
NasdaqGS:SSNC
NasdaqGS:SSNCProfessional Services

Should SS&C’s New WorkHQ AI Automation Platform Shift the Long‑Term Narrative for SSNC Investors?

In April 2026, SS&C Technologies Holdings launched SS&C Blue Prism WorkHQ, an agentic automation platform that unifies people, AI agents, APIs, and digital workers under a single, governed control plane to help enterprises run AI-enabled workflows with embedded security, auditability, and compliance. Built on SS&C’s own large-scale use of more than 4,000 digital workers and over 50 AI agents, WorkHQ aims to help customers shift from isolated AI pilots to governed, enterprise-wide automation...
NYSE:TSM
NYSE:TSMSemiconductor

Is It Too Late To Consider Taiwan Semiconductor Manufacturing (NYSE:TSM) After Its 1‑Year Surge?

Wondering whether Taiwan Semiconductor Manufacturing stock still offers value after its strong run, or if you might be arriving late to the story? The share price last closed at US$414.15, with returns of 4.6% over 7 days, 19.9% over 30 days, 29.6% year to date, 138.6% over 1 year, 413.9% over 3 years and 306.3% over 5 years. Recent headlines have focused on Taiwan Semiconductor Manufacturing's central role in global chip supply and its position in advanced manufacturing capacity. This...
NYSE:HLF
NYSE:HLFPersonal Products

A Look At Herbalife (HLF) Valuation After Solid First Quarter Earnings Results

First quarter results put Herbalife in focus Herbalife (HLF) reported first quarter sales of US$1,317.2 million and net income of US$61.9 million, with earnings per share from continuing operations ahead of the figures reported a year earlier. See our latest analysis for Herbalife. Herbalife's earnings release landed alongside concerns about higher input costs across the personal care sector, and the stock's recent 1 day share price return of an 11.86% decline contrasts with a very large 1...
NYSE:GRND
NYSE:GRNDInteractive Media and Services

Is Grindr (GRND) Offering Value After A 43% One Year Share Price Decline

If you are wondering whether Grindr stock is priced fairly or if the current level still leaves room for value, you need to look past headlines and into the numbers that shape valuation. Over the last month the share price has moved to US$13.81, with returns of 3.3% over 7 days, 12.4% over 30 days and 3.8% year to date, set against a 43.5% loss over the past year and a 124.2% gain over three years. Recent coverage has focused on Grindr as a listed platform business and how investors are...
NasdaqGS:ACIW
NasdaqGS:ACIWSoftware

ACI Worldwide (ACIW) Valuation Check After Q1 Earnings Beat And Raised 2026 Guidance

Stronger outlook after Q1 earnings surprise ACI Worldwide (ACIW) raised its full year 2026 revenue and adjusted EBITDA guidance after first quarter results exceeded analyst estimates and highlighted double digit growth in both revenue and adjusted EBITDA. The quarter also featured solid contributions from Real Time Payments and Merchant segments, alongside growth in new annual recurring revenue bookings. The upgraded outlook was received positively by investors following the announcement. See...
NasdaqGS:ATLC
NasdaqGS:ATLCConsumer Finance

Does Strong Q1 2026 Results and Mercury Deal Reframe the Bull Case for Atlanticus (ATLC)?

Atlanticus Holdings Corporation recently reported past first-quarter 2026 results, with net income rising to US$44.18 million and diluted earnings per share from continuing operations at US$2.23, both higher than a year earlier. Management highlighted that strong performance from the Credit as a Service business and the Mercury Financial acquisition were key drivers of the earnings improvement and revenue expansion. With Q1 earnings lifted by the Mercury Financial acquisition and Credit as a...
NYSE:MTX
NYSE:MTXChemicals

Minerals Technologies (MTX) Is Up 8.2% After Sharp Q1 Profit Turnaround And FMR Stake Spotlight

Minerals Technologies Inc. recently reported first-quarter 2026 results, with sales rising to US$546.9 million from US$491.8 million a year earlier and net income improving to US$36.2 million from a US$144 million loss. The swing from a basic loss per share from continuing operations of US$4.51 to earnings of US$1.17 highlights a sharp turnaround in profitability that may reframe how investors view the company’s earnings power. We’ll now explore how this sharp earnings turnaround, alongside...
NYSE:IHS
NYSE:IHSTelecom

Assessing IHS Holding (NYSE:IHS) Valuation After A Year Of Mixed Returns And Perceived Undervaluation

Key recent performance context IHS Holding (NYSE:IHS) has drawn investor attention after recent trading that left the stock near US$8.23, with year to date total return of about 12% and 1 year total return around 44%. Over the past month, the stock’s return has been slightly negative, while the past 3 months show a small positive move. This gives investors a mixed short term picture alongside stronger longer term performance. See our latest analysis for IHS Holding. For you as a shareholder,...
NYSE:APO
NYSE:APODiversified Financial

Is Apollo Global Management (APO) Pricing Reflect Its Strong Multi Year Share Price Performance

If you are wondering whether Apollo Global Management's current share price lines up with its underlying worth, this article walks through the key numbers in plain language. The stock last closed at US$127.79, with a 21.3% gain over the past 30 days, a 0.7% decline over 7 days, a 12.8% decline year to date and a 2.6% decline over the past year. This is set against a 110.8% return over 3 years and a 152.8% return over 5 years. Recent attention on Apollo Global Management has focused on how...
NYSE:CDP
NYSE:CDPOffice REITs

How Raised 2026 EPS Guidance At COPT Defense Properties (CDP) Has Changed Its Investment Story

COPT Defense Properties recently reported past first-quarter 2026 results, with revenue rising to US$200.64 million and net income to US$38.56 million, alongside diluted EPS of US$0.34 from continuing operations. Alongside these results, management raised full-year 2026 diluted EPS guidance to US$1.24–US$1.30 and set second-quarter guidance at US$0.31–US$0.33, signaling confidence in the company’s operating outlook. Next, we’ll examine how this higher full-year earnings guidance could...
NYSE:DHR
NYSE:DHRLife Sciences

Masimo Deal Approval Sets Stage For Danaher Growth And Valuation Re‑Rating

Masimo shareholders have officially approved the merger with Danaher (NYSE:DHR). The vote clears a key milestone for the acquisition and allows the deal process to move toward closing. The transaction is expected to expand Danaher's presence in diagnostics and medical technology once remaining conditions are met. For investors watching NYSE:DHR, this approval matters because it comes at a time when diagnostics, patient monitoring and broader medical technology are central to hospital and...
NasdaqGS:APLS
NasdaqGS:APLSBiotechs

Is It Too Late To Consider Apellis Pharmaceuticals (APLS) After Its 130% One Year Surge?

If you are trying to figure out whether Apellis Pharmaceuticals is attractively priced today, it helps to start with how the current market value lines up against different ways of estimating fair value. The stock last closed at US$41.01, with returns of 0.1% over 7 days, 0.8% over 30 days, 58.6% year to date and 130.3% over the past year, alongside 3 year and 5 year returns of 53.7% decline and 10.1% decline respectively. This gives a mixed picture for anyone thinking about entry or exit...
NasdaqCM:PRCH
NasdaqCM:PRCHSoftware

Does Porch Group (PRCH) Prioritize Growth Over Profitability With Its Evolving Business Model?

In late April 2026, Porch Group, Inc. reported first-quarter results showing sales of US$121.12 million, up from US$104.75 million a year earlier, while moving from net income of US$8.40 million to a net loss of US$4.71 million. At the same time, Porch Group shifted from earnings per share of US$0.08 to a loss of US$0.04, and followed up with non-deal roadshow presentations in Boston and New York to explain its evolving business model to investors. With first-quarter revenue growth...
OTCPK:FMCC
OTCPK:FMCCDiversified Financial

Assessing Freddie Mac (OTCPK:FMCC) Valuation After Recent Share Price Rebound

Recent performance snapshot for Federal Home Loan Mortgage Federal Home Loan Mortgage (FMCC) has drawn attention after a 1-month return of about 26%, contrasting with a year-to-date decline of roughly 31% and a 3-month decline of nearly 3%. See our latest analysis for Federal Home Loan Mortgage. The share price has recently swung higher, with a 30 day share price return of about 26% from a last close of US$7.14. However, this follows a weaker year to date share price return and contrasts with...
NYSE:VST
NYSE:VSTRenewable Energy

Vistra (VST) Margin Fall To 4.2% Challenges Bullish Earnings Growth Narrative

Vistra (VST) has wrapped up FY 2025 with fourth quarter revenue of US$4.6b, Basic EPS of US$0.55 and net income of US$185m, rounding out a trailing twelve month picture that totals US$17.7b in revenue, Basic EPS of US$2.22 and net income of US$752m. Over recent quarters, reported revenue has moved from US$4.0b in Q4 2024 to US$4.6b in Q4 2025, while quarterly Basic EPS has ranged from US$1.16 in Q4 2024 to US$0.55 most recently, setting up a results season where investors are weighing...
NasdaqCM:ENGN
NasdaqCM:ENGNBiotechs

enGene Therapeutics (ENGN) Is Down 80.6% After Mixed Phase 2 Bladder Cancer Data Update - What's Changed

Earlier this week, enGene Therapeutics reported interim Phase 2 LEGEND trial results for its bladder cancer gene therapy detalimogene voraplasmid, revealing a 54% complete response rate but weaker 12‑month durability than previously expected, alongside generally manageable side effects and low disease progression. The mixed efficacy profile has triggered analyst downgrades and shareholder-rights investigations, highlighting how a single data update can rapidly reshape perceptions of a...